ProShares S&P 500 Ex-Health Care ETF (SPXV) seeks to track the S&P 500 Ex-Health Care Index, which measures the performance of all S&P 500 companies except those classified in the health care sector. This large-cap equity ETF provides diversified exposure to approximately 400+ U.S. companies across all sectors excluding pharmaceuticals, biotechnology, medical devices, and health care services.
How It Works
SPXV uses a passively managed, market-capitalization-weighted approach that mirrors its benchmark index by holding all S&P 500 constituents except health care stocks. The fund maintains sector weights proportional to the modified index, with technology and financials typically receiving the largest allocations due to health care's exclusion. Rebalancing occurs quarterly to align with index changes and maintain the health care exclusion. Holdings are concentrated in mega-cap stocks, with the top 10 positions typically representing 25-30% of assets.
Key Features
- Eliminates health care sector exposure while maintaining broad S&P 500 diversification across remaining ten sectors
- Provides tactical allocation tool for investors seeking to underweight or hedge against health care regulatory risks
- Offers pure-play exposure to non-health care mega-cap growth with technology sector receiving amplified weighting
Risks
- This ETF can lose value when non-health care sectors underperform, particularly during periods when health care provides defensive characteristics during market stress
- Concentrated exposure to technology and other growth sectors creates higher volatility than the full S&P 500, potentially declining 35-45% in severe bear markets
- Sector exclusion strategy may underperform broad market during extended periods when health care stocks lead, missing 15%+ of S&P 500 market capitalization
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for tactical investors with 1-3 year time horizons seeking to reduce health care exposure due to regulatory concerns or valuation worries. Medium-to-high risk tolerance required given concentrated sector exposure. Appropriate for investors implementing sector rotation strategies or those with separate health care holdings elsewhere in their portfolio.